Advanced search
Publication Cover
Ultrastructural Pathology Volume 44, 2020 - Issue 4-6
Submit an article Journal homepage
1,711
Views
10
CrossRef citations to date
0
Altmetric
Case Reports

Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?

Mohammad ObeidatDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
,
Alexandra L IsaacsonDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
,
Stephanie J. ChenDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
,
Marina IvanovicDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
&
Danniele HolandaDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6872-2673
ORCID Icon
Pages 519-523 | Received 16 Oct 2020, Accepted 09 Nov 2020, Published online: 04 Dec 2020

References

  • Littlejohn E. Hydroxychloroquine use in the COVID-19 patient. Cleve Clin J Med. 2020: 1–4.
  • Costa RM, Martul EV, Reboredo JM, Cigarran S. Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease. Clin Kidney J. 2013;6(5):533–536. doi:10.1093/ckj/sft089.
  • Wu SZ, Liang X, Geng J, Zhang MB, Xie N, Su XY. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report. World J Clin Cases. 2019;7(24):4377–4383. doi:10.12998/wjcc.v7.i24.4377.
  • Das S, Bhowmick S, Tiwari S, Sen S. An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19). Clin Drug Investig. 2020;40(7):591–601. doi:10.1007/s40261-020-00927-1.
  • WHO. WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 2020. https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19.
  • Ding HJ, Denniston AK, Rao VK, Gordon C. Hydroxychloroquine-related retinal toxicity. Rheumatology (Oxford). 2016;55:957–967.
  • Stokkermans TJ, Goyal A, Bansal P, Trichonas G. Chloroquine and Hydroxychloroquine Toxicity. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC; 2020.
  • Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227. doi:10.1016/j.kint.2020.04.003.
  • Pintavorn P, Cook WJ. Progressive renal insufficiency associated with amiodarone-induced phospholipidosis. Kidney Int. 2008;74(10):1354–1357. doi:10.1038/ki.2008.229.
  • Reasor MJ, Kacew S. Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med (Maywood). 2001;226(9):825–830. doi:10.1177/153537020122600903.
  • Albay D, Adler SG, Philipose J, Calescibetta CC, Romansky SG, Cohen AH. Chloroquine-induced lipidosis mimicking Fabry disease. Modern Pathol. 2005;18(5):733–738. doi:10.1038/modpathol.3800344.
  • Bracamonte ER, Kowalewska J, Starr J, Gitomer J, Alpers CE. Iatrogenic phospholipidosis Mimicking Fabry disease. Am J Kidney Dis. 2006;48(5):844–850. doi:10.1053/j.ajkd.2006.05.034.
  • de Menezes Neves PDM, Machado JR, Custodio FB, et al. Ultrastructural deposits appearing as “zebra bodies” in renal biopsy: fabry disease?- comparative case reports. BMC Nephrol. 2017;18(1):157. doi:10.1186/s12882-017-0571-0.
  • Sperati CJ, Rosenberg AZ. Hydroxychloroquine-induced mimic of renal Fabry disease. Kidney Int. 2018;94(3):634. doi:10.1016/j.kint.2018.02.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.